Global Gamma knife Market Overview
Gamma Knife Market Size was valued at USD 0.51 Billion in 2022. The gamma knife market industry is projected to grow from USD 0.53 Billion in 2023 to USD 0.80 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.20% during the forecast period (2024 - 2032). The rising prevalence of brain tumors and disorders drives the demand for advanced treatment options like gamma knife therapy are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Gamma Knife Market Trends
- Integration with other technologies is driving the market growth
Market CAGR for integration with different technologies is a pivotal motive force propelling the Gamma Knife marketplace ahead. The seamless integration of gamma knife structures with advanced imaging technology and synthetic intelligence complements their precision and efficacy. This integration permits healthcare professionals to visualize and target brain lesions with unparalleled accuracy, contributing to higher patient effects. According to enterprise reviews, the market for neurosurgical technology, consisting of included gamma knife systems, is anticipated to grow steadily inside the coming years, pushed by the growing call for stylish and technologically advanced treatment options.
The growing occurrence of brain issues is a good sized aspect fueling the adoption of gamma knife technology. According to worldwide fitness businesses, there was a substantial boom in the prevalence of neurological conditions, such as brain tumors and useful problems, throughout exclusive age companies. This surge in mind problems necessitates revolutionary and precise treatment answers, making gamma knife remedy a desired choice. Market facts suggests an instantaneous correlation between the growing prevalence of mind disorders and the increasing adoption of gamma knife methods, reinforcing its position as an important participant within the neurosurgical landscape.
An essential driver pushing the Gamma Knife marketplace to new heights is the rise in healthcare expenditure. Governments and private entities are allocating massive finances to strengthen healthcare infrastructure and facilitate the adoption of advanced clinical technology. With multiplied economic help, healthcare institutions are more likely to put money into latest system like gamma knife systems. Market analysis exhibits a wonderful correlation between healthcare expenditure developments and the growth of the gamma knife market, emphasizing the pivotal position economic investments play inside the tremendous adoption of this modern generation. Thus, driving the Gamma knife market revenue.
Gamma knife Market Segment Insights
Gamma knife Disease Indication Insights
The Gamma knife market segmentation, based on Disease Indication includes Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, others. The Cancer segment dominated the market 2022. Increased healthcare spending worldwide allows for greater adoption of advanced medical technologies like the Gamma Knife.
Gamma knife Anatomy Insights
The Gamma knife market segmentation, based on Anatomy includes Head, Neck, others. The Head category generated the most revenue in 2022. The aging population is more prone to neurological conditions, leading to a growing demand for precise and effective treatment options.
Figure 1: Gamma knife Market, by Anatomy, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Gamma knife Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. Increased healthcare spending worldwide allows for greater adoption of advanced medical technologies like the Gamma Knife. Patients and healthcare professionals are becoming more aware of the benefits of gamma knife therapy, leading to increased acceptance. It is increasing demand for gamma knife Anatomys in North America.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: GAMMA KNIFE MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
North America Gamma knife market accounts for the second-largest market share due to the Supportive government policies and funding for healthcare infrastructure contribute to the growth of gamma knife technology. Further, the German Gamma knife market held the largest market share, and the UK Gamma knife market was the fastest growing market in the European region
The Asia-Pacific Gamma knife Market is expected to grow at the fastest CAGR from 2023 to 2032. The reputation of gamma knife therapy as a cutting-edge and efficient treatment option attracts international patients, boosting the growth of medical tourism. Patients and healthcare professionals are becoming more aware of the benefits of gamma knife therapy, leading to increased acceptance. Moreover, India Gamma knife market held the largest market share, and the Indian Gamma knife market was the fastest growing market in the Asia-Pacific region.
Gamma knife Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their Anatomy lines, which will help the Gamma knife market, grow even more. The competitive landscape of the Gamma Knife market is characterized by the presence of key players striving to offer innovative solutions and maintain a stronghold in the neurosurgical and radiation oncology sectors. The competitive landscape also includes emerging players and startups that are contributing to the growth and innovation within the Gamma Knife market. The continual advancements in technology, strategic partnerships, and a focus on expanding market presence are key strategies employed by companies to maintain a competitive edge in this dynamic and rapidly evolving sector, with important market developments including public Awareness, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, gamma knife industry must offer cost-effective Anatomy.
Creating novel and cutting-edge Anatomys, such as Brain Metastasis gamma knife Anatomys made with calcium in the gamma knife industry to benefit clients and increase the market sector. In recent years, the gamma knife industry has Brain Metastasis Investing in brand building activities to create a strong brand presence in the market. Major players in the gamma knife market, including Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc, MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, Hitachi, Ltd., and others, are attempting to increase market demand by investing in research and development operations.
Elekta, a leading player in the medical technology sector, specializes in providing advanced solutions for radiation therapy and radiosurgery. Headquartered in Stockholm, Sweden, Elekta has established a presence with a strong focus on improving cancer care outcomes. With a history dating back to the 1970s, Elekta has continually innovated in the field of oncology, offering cutting-edge technologies such as Gamma Knife radiosurgery systems. The company's commitment to precision and patient well-being is evident in its comprehensive product portfolio, which includes solutions for cancer treatment planning, delivery, and monitoring. Elekta's emphasis on research and development, coupled with strategic collaborations, positions it as a key player shaping the future of radiation therapy and radiosurgery on a scale.
Varian Medical Systems, headquartered in Palo Alto, California, is a renowned American company dedicated to advancing cancer care through its comprehensive range of oncology solutions. With a history spanning over seven decades, Varian has been at the forefront of innovation in radiation oncology, making significant contributions to the field. The company's diverse product offerings encompass radiation therapy, radiosurgery, and proton therapy systems. Varian's commitment to improving the accessibility and effectiveness of cancer treatments is evident in its emphasis on cutting-edge technology and patient-centric approaches. As a leader, Varian Medical Systems continues to play a pivotal role in shaping the landscape of cancer care by providing solutions that enhance the quality of life for patients worldwide.
Key Companies in the Gamma knife market include
- Elekta
- Varian Medical Systems
- Huiheng Medical, Inc.
- Akesis, Inc
- MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
- American Radiosurgery Inc.
- Panacea Medical Technologies Pvt. Ltd.
- Nordion (Canada) Inc.
- Accuray Incorporated
- Hitachi, Ltd.
Gamma knife Industry Developments
In October 2022: Elekta collaborated with Brainlab a medical technology company to enable neurosurgeons and radiation oncologists to use Brainlab’s iPlan software together with Elekta’s Leksell GammaPlan treatment planning for Gamma Knife radiosurgery. Through this collaboration, clinicians will be given the option to add the functionality of iPlan RT Image to the optimized dosimetry and precision of Leksell GammaPlan treatment planning.
In October 2021: Panacea Medical Technologies Pvt. Ltd. a medical equipment company received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next generation stereotactic body radiotherapy (SBRT)-enabled linear accelerator on a ring gantry platform.
Gamma knife Market Segmentation
Gamma knife Disease Indication Outlook
- Brain Metastasis
- Cancer
- Arteriovenous Malformation
- Trigeminal Neuralgia
- Others
Gamma knife Anatomy Outlook
Gamma knife Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 0.51 Billion |
Market Size 2023 |
USD 0.53 Billion |
Market Size 2032 |
USD 0.803 Billion |
Compound Annual Growth Rate (CAGR) |
5.20% (2023-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2019- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments CoveBrain Metastasis |
Disease Indication, Anatomy, and Region |
Geographies CoveBrain Metastasis |
North America, Europe, Asia Pacific, and the Rest of the World |
Countries CoveBrain Metastasis |
The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc, MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, Hitachi, Ltd. |
Key Market Opportunities |
The development of new applications for Gamma Knife can broaden its market reach and appeal |
Key Market Dynamics |
The increasing prevalence of cancer, particularly brain tumors, is a major driver for the Gamma Knife market |
Frequently Asked Questions (FAQ) :
The Gamma knife market size was valued at USD 0.51 Billion in 2022.
The Global market is projected to grow at a CAGR of 5.20% during the forecast period, 2023-2032.
North America had the largest share in the Global market
The key players in the market are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc, MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, Hitachi, Ltd.
The Cancer category dominated the market in 2022.
The Head had the largest share in the Global market.